{"id":"NCT00874120","sponsor":"Bayer","briefTitle":"Safety Study Comparing Phenylephrine HCL Extended Release Tablets 30 mg and Placebo (Study CL2007-07)(P07529)(COMPLETED)","officialTitle":"Randomized, Placebo-Controlled, Double-Blind, Two-Way Crossover Study to Evaluate the Effects of Phenylephrine HCl Extended-Release Tablets 30 mg Compared to Placebo on Ambulatory Blood Pressure","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2008-12","primaryCompletion":"2009-02","completion":"2009-02","firstPosted":"2009-04-02","resultsPosted":"2010-07-05","lastUpdate":"2015-03-11"},"enrollment":116,"design":{"allocation":"RANDOMIZED","model":"CROSSOVER","masking":"DOUBLE","primaryPurpose":null},"conditions":["Blood Pressure","Human Experimentation"],"interventions":[{"type":"DRUG","name":"Phenylephrine Hydrochloride (HCl) Extended-Release tablets 30 mg","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Phenylephrine HCl Extended-Release tablets 30 mg","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"Randomized, placebo-controlled double-blind, crossover design study; 116 subjects randomized on Day 1 to obtain 98 completed subjects. Study will be composed of a 7-day period of therapy with randomized active or placebo treatment with a subsequent 6-8 day washout period, followed by a second 7-day period of double-blind therapy with the other agent. Ambulatory blood pressure measurement will be performed beginning on Day 7 of each treatment period following administration of the study drug.","primaryOutcome":{"measure":"Average Systolic Blood Pressure (SBP) Readings for a 5-hour Range Around the Time of Maximum Concentration (Tmax).","timeFrame":"24 hours after final dose of each 7-day treatment period.","effectByArm":[{"arm":"Phenylephrine","deltaMin":118.3,"sd":9.24},{"arm":"Placebo","deltaMin":118.6,"sd":9.38}],"pValues":[{"comp":"OG000 vs OG001","p":"0.5480"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":12,"exclusionCount":14},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":114},"commonTop":[]}}